Fred Hutch

Ten Washington state organizations received up to $15,000 each from Fred Hutch’s Community Grants Program to support the health needs of underserved communities across the state. This year brought a surge in applications, reflecting growing need and community-driven innovation. Read more: https://bit.ly/4fkKhH1

When most people think of cancer care, they rarely associate it with what goes on behind the scenes to create life-saving treatments. For starters, developing cell and gene therapies is pricey, and maintaining the manufacturing technology and environment is equally challenging. Supervising the minutiae of the machinery that fuels the Therapeutic Products Program (TPP) at Fred Hutch falls to Folashade “Shade” Otegbeye, MBChB, MPH. “Part of what we want to do is innovate processes in a way that recognizes the regulations and quality standards that govern the products we administer,” said Otegbeye. “We want to make sure we keep up with innovation and can rapidly translate what researchers are doing in the lab to the bedside." Otegbeye will get an assist in her efforts to innovate as the new holder of the Fleischauer Family Endowed Chair in Cell and Gene Therapy Translation. Read more: https://bit.ly/3U4dpZt

At Fred Hutch, researchers are encouraged to explore new ideas and collaborate with one another. “Remember, the vast majority of advanced cancers are still not cured,” says Thomas J. Lynch Jr., MD, president and director of Fred Hutch and holder of the Raisbeck Endowed Chair. “And that problem is not an engineering problem. It’s an ideas problem. We need to continue to invest in basic science to be able to drive ideas that give us new opportunities to improve cures.” Groundbreaking research efforts from the Women’s Health Initiative to the Transformative Rare Cancer Initiative represent just two of the many research initiatives and programs Fred Hutch leads that are driving progress across a broad spectrum of diseases. Read more from the The Seattle Times: https://bit.ly/46wFHTP

At first glance, art and science might seem like opposite worlds — one driven by imagination and emotion, the other by data and precision — but at their core, both seek to explore and explain the world around us. When these two fields intersect, they spark creativity, deepen understanding and invite new ways of interpreting ideas. Two years in the making, SxAffold is a new initiative designed to spark meaningful collaboration between scientists and artists. In early June, the program, sponsored by Brotman Baty Institute, launched its inaugural cohort — six artists working across various media — who came together for a fully funded, week-long workshop at Fred Hutch. "The main thing I’m really excited about with SxAffold and other projects that bring together science and art is the idea that we can reconstruct and redefine how scientists and artists might interact," said SxAffold organizer and Fred Hutch assistant professor Nasa Sinnott-Armstrong, PhD. Read more: https://bit.ly/3UIiOpc

New research from University of Washington, Microsoft Research's AI for Good Lab and Fred Hutch shows how AI technology can spot breast cancer in MRI scans more accurately than current digital methods, while also pinpointing exactly where suspicious tissue is located — a breakthrough that could make the sensitive screening tool available to more women. The system takes a novel approach by learning what normal breast tissue looks like, then flagging anything unusual, which is the opposite of how cancer-detection AI has typically been built. When it identifies potential cancer, it creates a visual heatmap showing radiologists precisely where to look. Read more: https://bit.ly/3U0jl5J

Fred Hutch is seeking a dedicated physician-scientist with a strong focus on T-cell Lymphoma and B-cell Diseases, and a passion for clinical and translational research in hematologic malignancies, especially lymphoma. Learn more and apply: https://lnkd.in/g8Cs6hs3

She’s a cancer survivor, a longtime cancer advocate, and a scientist-in-the-making. Meet Mercy Haub, Seafair's first-ever Community Hero! Mercy was honored at this year’s Seafair Torchlight Parade for her incredible dedication to cancer research advocacy. Through her work with Fred Hutch, Make-A-Wish and the Leukemia & Lymphoma Society, she's already making a lasting impact for patients and their families. Her mission is deeply personal: Mercy is a cancer survivor, now approaching five years in remission after being diagnosed with lymphoma in high school. That experience sparked her passion for science. She joined Fred Hutch’s Summer High School Internship Program and spent a gap year working in the lab of Dr. Hootie Warren. This Fall, she'll be a junior at Stanford University studying human biology on the pre-med track with her sights set on becoming a cancer researcher.

Summer internship season is well underway at Fred Hutch. Meet the 2025 Summer High School Internship Program (SHIP) and Pathways Undergraduate Research Interns. Over the next few weeks, they’ll collaborate with faculty mentors, dive into independent research projects, attend workshops and panel discussion on a variety of science topics, as well as building a network community among Fred Hutch scientists, staff and fellow interns. Learn more about the programs: https://bit.ly/450FAgN

Fred Hutch is seeking a clinician-scholar committed to advancing leading-edge research and delivering world-class treatment in multiple myeloma and related plasma cell disorders. Learn more and apply: https://lnkd.in/gRiRZ4jj

Breast cancer recurrences can often be more complex than newly diagnosed early-stage breast cancers. “Patients can benefit from seeing a breast cancer specialist in radiation, medical and surgical oncology, as these cancers can be less common and more complex to treat,” said Fred Hutch radiation oncologist Kylie Kang, MD. “It usually requires careful treatment management considerations, especially with a history of prior radiation.” After a biopsy revealed a locoregional recurrence of her ductal breast cancer, Teah, Dr. Kang and her medical team at Fred Hutch decided proton therapy was the best radiation treatment approach. Read more: https://lnkd.in/g29-YrkN